Vanguard Fiduciary Trust’s Kezar Life Sciences KZR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,201	Closed	-$306K	–	4121
2026 Q1	$306K	Buy	+41,201	New	+$268K	﹤0.01%	3378

Vanguard Fiduciary Trust's KZR Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 41,201 shares — an estimated $306K sold.

Vanguard Fiduciary Trust first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $306K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Vanguard Fiduciary Trust reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Vanguard Fiduciary Trust sold 41,201 Kezar Life Sciences shares in Q2 2026, an estimated $306K.
Vanguard Fiduciary Trust first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
Vanguard Fiduciary Trust's Kezar Life Sciences position peaked at $306K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.